81 |
The PARP1 inhibitor BMN 673 exhibits immunoregulatory effects in a Brca1(-/-) murine model of ovarian cancer Huang J, Wang L, Cong ZY, Amoozgar Z, Kiner E, Xing DY, Orsulic S, Matulonis U, Goldberg MS Biochemical and Biophysical Research Communications, 463(4), 551, 2015 |
82 |
Leukocyte-associated immunoglobulin-like receptor-1 expressed in epithelial ovarian cancer cells and involved in cell proliferation and invasion Cao QZ, Fu AL, Yang SD, He XL, Wang Y, Zhang XS, Zhou JD, Luan XY, Yu WZ, Xue JN Biochemical and Biophysical Research Communications, 458(2), 399, 2015 |
83 |
beta-Catenin expression is regulated by an IRES-dependent mechanism and stimulated by paclitaxel in human ovarian cancer cells Fu QY, Chen Z, Gong XH, Cai YF, Chen Y, Ma X, Zhu RY, Jin J Biochemical and Biophysical Research Communications, 461(1), 21, 2015 |
84 |
Transforming growth factor-alpha induces human ovarian cancer cell invasion by down-regulating E-cadherin in a Snail-independent manner Qiu X, Cheng JC, Klausen C, Fan QL, Chang HM, So WK, Leung PCK Biochemical and Biophysical Research Communications, 461(1), 128, 2015 |
85 |
OCT4 mediates FSH-induced epithelial-mesenchymal transition and invasion through the ERK1/2 signaling pathway in epithelial ovarian cancer Liu L, Zhang J, Fang C, Zhang ZB, Feng YJ, Xi XW Biochemical and Biophysical Research Communications, 461(3), 525, 2015 |
86 |
EpCAM is up-regulated by EGF via ERK1/2 signaling and suppresses human epithelial ovarian cancer cell migration Fan QL, Cheng JC, Qiu X, Chang HM, Leung PCK Biochemical and Biophysical Research Communications, 457(3), 256, 2015 |
87 |
Segregation of Ovarian Cancer Stage Exploiting Spectral Biomarkers Derived from Blood Plasma or Serum Analysis: ATR-FTIR Spectroscopy Coupled with Variable Selection Methods Lima KMG, Gajjar KB, Martin-Hirsch PL, Martin FL Biotechnology Progress, 31(3), 832, 2015 |
88 |
Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells Zi D, Zhou ZW, Yang YJ, Huang L, Zhou ZL, He SM, He ZX, Zhou SF International Journal of Molecular Sciences, 16(11), 27228, 2015 |
89 |
High Levels of KAP1 Expression Are Associated with Aggressive Clinical Features in Ovarian Cancer Cui YF, Yang SB, Fu X, Feng JW, Xu SL, Ying GG International Journal of Molecular Sciences, 16(1), 363, 2015 |
90 |
Biocompatible APTES-PEG Modified Magnetite Nanoparticles: Effective Carriers of Antineoplastic Agents to Ovarian Cancer Javid A, Ahmadian S, Saboury AA, Kalantar SM, Rezaei-Zarchi S, Shahzad S Applied Biochemistry and Biotechnology, 173(1), 36, 2014 |